These findings collectively highlight FoxP1 as a negative regulator of MEF2, whose up‐regulation in response to tumour burden contributes to the repression of MEF2 target gene transcription, ultrastructural alterations and to the normal atrophy process. Here, FOXP1 is linked to neoplasm.